Athyrium Capital Management
New York City, New Yorkathyrium.com
Overview
Athyrium Capital Management is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium has substantial investment experience in the healthcare sector across a wide range of asset classes including public equity, private equity, fixed income, royalties, and other structured securities. The firm invests across all healthcare verticals including biopharma, medical devices and products, and healthcare-focused services .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vita Health | Jan 2024 | Series A | Co-investor |
| RVL Pharmaceuticals | Aug 2023 | Private Placement | Co-investor |
| Vita Health | Dec 2022 | Seed | Co-investor |
| RVL Pharmaceuticals | Aug 2022 | Private Placement | Lead |
| RVL Pharmaceuticals | Aug 2022 | Debt | Lead |
Key People
Jeffrey Ferrell
Managing Partner
Courtney Paul
Associate General Counsel Vice President, Investor Relations
Michelle Fang Jordan
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.